🔎 Trials Near Me

Home › Flu › NCT06807840

Flu Infection at UPHS

RecruitingObservational study

Evaluating Immune Imprinting in the Context of Influenza Virus Infections

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

1. Provision of signed and dated informed consent form
2. Stated willingness to comply with all study procedures and availability for the duration of the study
3. Aged 18 years and older
4. Influenza positive test result performed within the University of Pennsylvania Health System

Exclusion Criteria:

1. Known latex allergy
2. Immunosuppression as a result of an underlying illness or treatment with immunosuppressive or cytotoxic drugs, or use of anticancer chemotherapy or radiation therapy within the preceding 36 months
3. Pregnancy due to the volume of blood collected in this study
4. Treatment with immunoglobulin or another blood product within the 3 months prior to enrollment in this study
5. Any neoplastic disease (excluding non-melanoma skin cancer or prostate cancer that is stable in the absence of therapy) or a history of any hematological malignancy ("active" is defined as having received treatment within the past 5 years)
6. Known acute or chronic medical condition that, in the opinion of the investigator or appropriate sub-investigator, would interfere with the evaluation of immune responses
7. Intends to donate blood during the study period
8. A known human immunodeficiency virus, hepatitis B, or hepatitis C infection
9. Any condition that would, in the opinion of the site investigator, place the subject at an unacceptable risk of injury or render the subject unable to meet the requirements of the protocol
10. Prolonged inpatient hospitalization that disrupts or interferes with study procedures.
11. Weigh less than 110lbs

About the study

Cellular and humoral immune responses in individuals with active influenza infection will be assessed. Each year, up to 50 participants will be enrolled. The investigators hypothesize that influenza infection will elicit mostly memory immune responses rather than de novo immune responses to infection.

What is being tested

Sponsor: University of Pennsylvania · Participants: 50 · Started: Jan 27, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06807840

Locations in the U.S.

PennsylvaniaPenn Presbyterian Medical Center, Philadelphia

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.